TissueGen’s patented extrusion process enables delivery of the broadest range of temperature-sensitive pharmaceuticals and biologics previously impossible to incorporate in implantable devices. In more ways than ever, medical device developers can now deploy advanced drug delivery with ELUTE® fiber – an incredible breakthrough that drastically expands the drugs deliverable via implantable fibers.
TissueGen’s patented room temperature fiber extrusion technology preserves the biological activity of incorporated drugs and enables an entirely new format for drug delivery via biodegradable ELUTE fibers.
ELUTE fiber is driving a paradigm shift in nerve regeneration through controlled, sustained delivery of sensitive biologics including growth factors from biomimetic three-dimensional structures.
Tailored for devices that require both mechanical and pharmaceutical support, ELUTE fiber is ideal for tissue scaffolds and stents, including TissueGen’s ARCHER™ stent and drug-eluting stent for the biliary, PAD, and DVT markets.